We are a clinical stage biopharmaceutical company that integrates proprietary gene editing technology, transgenic mouse platforms to generate fully human antibodies, comprehensive animal models and high-throughput in vivo antibody discovery. We have established fully integrated research and development capabilities ranging from early target discovery to clinical development. Our focus on research and development and technological innovation serves as the cornerstone of our continuing growth. We intend to develop and commercialize first-in-class or best-in-class drugs to contribute to the improvement of human health worldwide.
Using specialized animal models and state-of-the-art screening technologies, we can generate fully human antibodies for your application in an accelerated time frame.Learn More
Efficacy & Toxicity Studies
We evaluate therapeutic antibody efficacy & toxicity in vitro and in vivo using CDX tumor models, humanized immune checkpoint mice and human immune-reconstituted models.Learn More
Gene Editing Services
Using CRISPR/Cas9-based technologies and embryonic stem cell targeting, we can create conventional and conditional knock-in and knock-out models, gene-edited cell lines and transgenic animal models.Learn More